Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 944
- 试验地点
- 5
- 主要终点
- Self-reported Smoking Abstinence
研究概览
简要总结
This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.
详细描述
This trial is a pragmatic randomized trial targeting the care of current smokers who are participating in lung cancer screening at two VA sites. Primary care providers at these sites will be randomized, and half will be offered tools to help integrate proactive smoking cessation support into the lung cancer screening process. Key proactive elements include proactive telephone outreach to all current smokers by a VA Quitline counselor that follows mailed results letters, and providing providers guidance in offering proactive cessation medication support as part of the lung cancer screening process.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- — 至 80 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Providers who schedule patients for a lung cancer screening at either of the two VA sites.
- •Patients who participate in lung cancer screening and are current smokers at the time of scheduling their screening exam.
排除标准
- •Providers who currently systematically prescribe cessation support medication to all current smokers will be excluded.
- •Patients with urgent findings requiring biopsy/immediate attention on the screening CT will be excluded.
- •Patients with a prior diagnosis of lung cancer or who are receiving active therapy for any cancer, except skin cancer, will be excluded.
- •Patients previously diagnosed with cognitive impairment, dementia, or severe behavioral disorders, or have an indication in chart review of difficulty communicating or participating in telephone counseling sessions will be excluded.
结局指标
主要结局
Self-reported Smoking Abstinence
时间窗: 12 months after lung cancer screening visit
The primary outcome measure is self-reported abstinence from smoking 12 months after lung cancer screening, using information obtained from study surveys and electronic medical records. This measure only applies to patient enrollees.
次要结局
- Cost of Smoking Cessation Care(Time period from lung cancer screening through 12 months after lung cancer screening)
- Patients' Experience With Telephone Counseling(3 months after lung cancer screening visit)
- Patients' Motivational Assessment(12 months after lung cancer screening visit)
- Patients' Perception of Susceptibility to Harm(3 months after lung cancer screening visit)
- Patients' Self-efficacy Assessment(12 months after lung cancer screening visit)